Marshall Wace North America’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-68,335
| Closed | -$10.5M | – | 1515 |
|
|
2020
Q4 | $10.5M | Buy |
+68,335
| New | +$10.5M | 0.05% | 367 |
|
|
2019
Q3 | – | Sell |
-4,945
| Closed | -$233K | – | 1342 |
|
|
2019
Q2 | $233K | Buy |
+4,945
| New | +$233K | ﹤0.01% | 1015 |
|
|
2018
Q2 | – | Sell |
-476,762
| Closed | -$21.8M | – | 1432 |
|
|
2018
Q1 | $21.8M | Buy |
+476,762
| New | +$21.8M | 0.11% | 216 |
|